Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer.

about

Impact of 68Ga-PSMA-PET imaging on target volume definition and guidelines in radiation oncology - a patterns of failure analysis in patients with primary diagnosis of prostate cancer.

Item

http://www.wikidata.org/entity/Q52680980

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@en

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@nl

type

Item

label

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@en

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@nl

prefLabel

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@en

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@nl

P1476

Impact of 68Ga-PSMA-PET imagin ...... diagnosis of prostate cancer.

@en

P2093

G Habl

http://www.w3.org/2001/XMLSchema#string

J Gschwend

http://www.w3.org/2001/XMLSchema#string

M Devecka

http://www.w3.org/2001/XMLSchema#string

M Eiber

http://www.w3.org/2001/XMLSchema#string

M Schwaiger

http://www.w3.org/2001/XMLSchema#string

S E Combs

http://www.w3.org/2001/XMLSchema#string

P2860

(68)Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer

Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.

Predicting pelvic lymph node involvement in current-era prostate cancer.

PET/MR in prostate cancer: technical aspects and potential diagnostic value.

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.

68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: Individualized medicine or new standard in salvage treatment.

68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

P2888

s13014-018-0977-2

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-018-0977-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tobias Maurer

K Schiller

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101279274

http://www.w3.org/2001/XMLSchema#string

P698

29490670

http://www.w3.org/2001/XMLSchema#string

P932

5831712

http://www.w3.org/2001/XMLSchema#string